Published in PLoS Pathog on May 29, 2009
A physical and regulatory map of host-influenza interactions reveals pathways in H1N1 infection. Cell (2009) 4.98
Factors affecting reproducibility between genome-scale siRNA-based screens. J Biomol Screen (2010) 4.47
Genomic screening with RNAi: results and challenges. Annu Rev Biochem (2010) 3.08
The genomic sequence of the Chinese hamster ovary (CHO)-K1 cell line. Nat Biotechnol (2011) 2.87
HIV Restriction Factors and Mechanisms of Evasion. Cold Spring Harb Perspect Med (2012) 2.72
Immunology and the elusive AIDS vaccine. Nature (2010) 2.26
Specific inhibition of diverse pathogens in human cells by synthetic microRNA-like oligonucleotides inferred from RNAi screens. Proc Natl Acad Sci U S A (2014) 2.25
Systems biology in immunology: a computational modeling perspective. Annu Rev Immunol (2011) 2.15
Single-cell analysis of population context advances RNAi screening at multiple levels. Mol Syst Biol (2012) 2.13
Studies of endogenous retroviruses reveal a continuing evolutionary saga. Nat Rev Microbiol (2012) 1.94
Genome-wide mRNA expression correlates of viral control in CD4+ T-cells from HIV-1-infected individuals. PLoS Pathog (2010) 1.90
The Mediator complex and transcription regulation. Crit Rev Biochem Mol Biol (2013) 1.64
Adenosine deaminases acting on RNA (ADARs) are both antiviral and proviral. Virology (2011) 1.62
High-content genome-wide RNAi screens identify regulators of parkin upstream of mitophagy. Nature (2013) 1.59
The evolution of HIV-1 and the origin of AIDS. Philos Trans R Soc Lond B Biol Sci (2010) 1.54
RNAi screening comes of age: improved techniques and complementary approaches. Nat Rev Mol Cell Biol (2014) 1.54
Two-stepping through time: mammals and viruses. Trends Microbiol (2011) 1.54
Perturbation of the P-body component Mov10 inhibits HIV-1 infectivity. PLoS One (2010) 1.51
RNAi screening: new approaches, understandings, and organisms. Wiley Interdiscip Rev RNA (2011) 1.48
Pathway-based analysis of genome-wide siRNA screens reveals the regulatory landscape of APP processing. PLoS One (2015) 1.47
Nuclear landscape of HIV-1 infection and integration. Nat Rev Microbiol (2016) 1.41
Nucleoporin NUP153 phenylalanine-glycine motifs engage a common binding pocket within the HIV-1 capsid protein to mediate lentiviral infectivity. PLoS Pathog (2013) 1.36
Host hindrance to HIV-1 replication in monocytes and macrophages. Retrovirology (2010) 1.33
C911: A bench-level control for sequence specific siRNA off-target effects. PLoS One (2012) 1.32
Inhibition of HIV-1 infection by TNPO3 depletion is determined by capsid and detectable after viral cDNA enters the nucleus. Retrovirology (2011) 1.32
DEAD-box protein DDX3 associates with eIF4F to promote translation of selected mRNAs. EMBO J (2012) 1.31
Host genes associated with HIV/AIDS: advances in gene discovery. Trends Genet (2010) 1.25
CBFβ stabilizes HIV Vif to counteract APOBEC3 at the expense of RUNX1 target gene expression. Mol Cell (2013) 1.23
RNA helicase A modulates translation of HIV-1 and infectivity of progeny virions. Nucleic Acids Res (2009) 1.22
HIV-1 assembly in macrophages. Retrovirology (2010) 1.20
Uncovering the global host cell requirements for influenza virus replication via RNAi screening. Microbes Infect (2011) 1.19
New insights into HIV assembly and trafficking. Physiology (Bethesda) (2011) 1.18
Viruses and antiviral immunity in Drosophila. Dev Comp Immunol (2013) 1.16
Large scale RNAi reveals the requirement of nuclear envelope breakdown for nuclear import of human papillomaviruses. PLoS Pathog (2014) 1.16
Patterns of HIV-1 protein interaction identify perturbed host-cellular subsystems. PLoS Comput Biol (2010) 1.11
Retroviral integration site selection. Viruses (2010) 1.10
A CRISPR-Based Screen Identifies Genes Essential for West-Nile-Virus-Induced Cell Death. Cell Rep (2015) 1.10
Host cofactors and pharmacologic ligands share an essential interface in HIV-1 capsid that is lost upon disassembly. PLoS Pathog (2014) 1.09
Characterization of the HIV-1 RNA associated proteome identifies Matrin 3 as a nuclear cofactor of Rev function. Retrovirology (2011) 1.08
Genome-wide screening using RNA interference to study host factors in viral replication and pathogenesis. Exp Biol Med (Maywood) (2011) 1.07
Role of human immunodeficiency virus type 1 integrase in uncoating of the viral core. J Virol (2010) 1.07
Host genetics and HIV-1: the final phase? PLoS Pathog (2010) 1.06
A genome-wide association study of resistance to HIV infection in highly exposed uninfected individuals with hemophilia A. Hum Mol Genet (2013) 1.05
A role for microRNA-155 modulation in the anti-HIV-1 effects of Toll-like receptor 3 stimulation in macrophages. PLoS Pathog (2012) 1.05
What have RNAi screens taught us about viral-host interactions? Curr Opin Microbiol (2009) 1.04
Matrin 3 is a co-factor for HIV-1 Rev in regulating post-transcriptional viral gene expression. Retrovirology (2011) 1.04
Virus-producing cells determine the host protein profiles of HIV-1 virion cores. Retrovirology (2012) 1.04
A physical interaction network of dengue virus and human proteins. Mol Cell Proteomics (2011) 1.03
GPS-Prot: a web-based visualization platform for integrating host-pathogen interaction data. BMC Bioinformatics (2011) 1.03
Reverse Transcriptase and Cellular Factors: Regulators of HIV-1 Reverse Transcription. Viruses (2009) 1.03
Viral and cellular requirements for the nuclear entry of retroviral preintegration nucleoprotein complexes. Viruses (2013) 1.03
HIV-1, human interaction database: current status and new features. Nucleic Acids Res (2014) 1.02
Systems vaccinology: its promise and challenge for HIV vaccine development. Curr Opin HIV AIDS (2012) 1.01
HIV-1 capsid undergoes coupled binding and isomerization by the nuclear pore protein NUP358. Retrovirology (2013) 1.01
siRNA and shRNA screens advance key understanding of host factors required for HIV-1 replication. Retrovirology (2009) 1.01
Limited agreement of independent RNAi screens for virus-required host genes owes more to false-negative than false-positive factors. PLoS Comput Biol (2013) 1.01
Coordinate roles of Gag and RNA helicase A in promoting the annealing of formula to HIV-1 RNA. J Virol (2010) 1.01
Systematic approaches towards the development of host-directed antiviral therapeutics. Int J Mol Sci (2011) 1.01
Quantitative proteomic analysis of HIV-1 infected CD4+ T cells reveals an early host response in important biological pathways: protein synthesis, cell proliferation, and T-cell activation. Virology (2012) 1.01
A simple method for analyzing actives in random RNAi screens: introducing the "H Score" for hit nomination & gene prioritization. Comb Chem High Throughput Screen (2012) 1.00
Computational prediction of host-parasite protein interactions between P. falciparum and H. sapiens. PLoS One (2011) 1.00
Bringing it all together: big data and HIV research. AIDS (2013) 0.99
IL-27 inhibits HIV-1 infection in human macrophages by down-regulating host factor SPTBN1 during monocyte to macrophage differentiation. J Exp Med (2013) 0.98
The major cellular sterol regulatory pathway is required for Andes virus infection. PLoS Pathog (2014) 0.98
A systematic analysis of host factors reveals a Med23-interferon-λ regulatory axis against herpes simplex virus type 1 replication. PLoS Pathog (2013) 0.98
The use of RNAi-based screens to identify host proteins involved in viral replication. Future Microbiol (2010) 0.97
Cell-based genomic screening: elucidating virus-host interactions. Curr Opin Virol (2012) 0.97
Host genes important to HIV replication and evolution. Cold Spring Harb Perspect Med (2012) 0.95
Efficient SIVcpz replication in human lymphoid tissue requires viral matrix protein adaptation. J Clin Invest (2012) 0.95
BiologicalNetworks--tools enabling the integration of multi-scale data for the host-pathogen studies. BMC Syst Biol (2011) 0.95
In vivo functions of CPSF6 for HIV-1 as revealed by HIV-1 capsid evolution in HLA-B27-positive subjects. PLoS Pathog (2014) 0.94
The virus as metabolic engineer. Biotechnol J (2010) 0.94
Antiviral RNAi: translating science towards therapeutic success. Pharm Res (2011) 0.94
Gyrase B inhibitor impairs HIV-1 replication by targeting Hsp90 and the capsid protein. J Biol Chem (2010) 0.94
Interaction of the HIV-1 intasome with transportin 3 protein (TNPO3 or TRN-SR2). J Biol Chem (2012) 0.94
The host interactome of influenza virus presents new potential targets for antiviral drugs. Rev Med Virol (2011) 0.94
Novel HIV-1 therapeutics through targeting altered host cell pathways. Expert Opin Biol Ther (2009) 0.94
Insights into cellular factors that regulate HIV-1 replication in human cells. Biochemistry (2011) 0.92
Towards semi-automated curation: using text mining to recreate the HIV-1, human protein interaction database. Database (Oxford) (2012) 0.92
Characterization of LEDGF/p75 genetic variants and association with HIV-1 disease progression. PLoS One (2012) 0.92
Novel HIV-1 knockdown targets identified by an enriched kinases/phosphatases shRNA library using a long-term iterative screen in Jurkat T-cells. PLoS One (2010) 0.91
Comprehensive identification of host modulators of HIV-1 replication using multiple orthologous RNAi reagents. Cell Rep (2014) 0.91
Network-based prediction and analysis of HIV dependency factors. PLoS Comput Biol (2011) 0.91
Systematic analysis of RNAi reports identifies dismal commonality at gene-level and reveals an unprecedented enrichment in pooled shRNA screens. Comb Chem High Throughput Screen (2013) 0.91
Identifying proteins controlling key disease signaling pathways. Bioinformatics (2013) 0.90
A host of factors regulating influenza virus replication. Viruses (2010) 0.90
The DEAD-box helicase DDX3 substitutes for the cap-binding protein eIF4E to promote compartmentalized translation initiation of the HIV-1 genomic RNA. Nucleic Acids Res (2013) 0.89
Phage display-directed discovery of LEDGF/p75 binding cyclic peptide inhibitors of HIV replication. Mol Ther (2012) 0.89
High-throughput RNA interference screens integrative analysis: Towards a comprehensive understanding of the virus-host interplay. World J Virol (2013) 0.89
Positive selection of primate genes that promote HIV-1 replication. Virology (2014) 0.89
A review on computational systems biology of pathogen-host interactions. Front Microbiol (2015) 0.88
Expression analysis of LEDGF/p75, APOBEC3G, TRIM5alpha, and tetherin in a Senegalese cohort of HIV-1-exposed seronegative individuals. PLoS One (2012) 0.88
Isolation of homozygous mutant mouse embryonic stem cells using a dual selection system. Nucleic Acids Res (2011) 0.88
Shedding light on filovirus infection with high-content imaging. Viruses (2012) 0.87
Functional genomic and high-content screening for target discovery and deconvolution. Expert Opin Drug Discov (2012) 0.87
Heterogeneous susceptibility of circulating SIV isolate capsids to HIV-interacting factors. Retrovirology (2013) 0.87
Knockdown of MAP4 and DNAL1 produces a post-fusion and pre-nuclear translocation impairment in HIV-1 replication. Virology (2011) 0.86
Simian immunodeficiency virus and human immunodeficiency virus type 1 matrix proteins specify different capabilities to modulate B cell growth. J Virol (2014) 0.86
Analysis of HIV-1 Gag protein interactions via biotin ligase tagging. J Virol (2015) 0.86
DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol (2003) 84.79
Global landscape of protein complexes in the yeast Saccharomyces cerevisiae. Nature (2006) 24.29
An automated method for finding molecular complexes in large protein interaction networks. BMC Bioinformatics (2003) 15.42
A whole-genome association study of major determinants for host control of HIV-1. Science (2007) 15.19
The druggable genome. Nat Rev Drug Discov (2002) 13.61
HIV-1 integration in the human genome favors active genes and local hotspots. Cell (2002) 12.60
Identification of host proteins required for HIV infection through a functional genomic screen. Science (2008) 12.44
Transcription start regions in the human genome are favored targets for MLV integration. Science (2003) 12.21
Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding. Cell (2001) 12.00
A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA. Cell (1998) 10.14
Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication. Cell (2008) 8.41
Retroviral DNA integration: ASLV, HIV, and MLV show distinct target site preferences. PLoS Biol (2004) 8.27
The protein network of HIV budding. Cell (2003) 7.82
Crystal structure of human cyclophilin A bound to the amino-terminal domain of HIV-1 capsid. Cell (1996) 6.74
Visualization of the intracellular behavior of HIV in living cells. J Cell Biol (2002) 6.59
Genome-scale RNAi screen for host factors required for HIV replication. Cell Host Microbe (2008) 6.24
RNAi: nature abhors a double-strand. Curr Opin Genet Dev (2002) 5.74
RNA interference screen for human genes associated with West Nile virus infection. Nature (2008) 4.93
HIV-1 integrase forms stable tetramers and associates with LEDGF/p75 protein in human cells. J Biol Chem (2002) 4.91
A role for LEDGF/p75 in targeting HIV DNA integration. Nat Med (2005) 4.88
The importin-beta family member Crm1p bridges the interaction between Rev and the nuclear pore complex during nuclear export. Curr Biol (1997) 4.35
An essential role for LEDGF/p75 in HIV integration. Science (2006) 4.18
Drosophila RNAi screen identifies host genes important for influenza virus replication. Nature (2008) 4.18
LEDGF/p75 is essential for nuclear and chromosomal targeting of HIV-1 integrase in human cells. J Biol Chem (2003) 3.97
LEDGF/p75 functions downstream from preintegration complex formation to effect gene-specific HIV-1 integration. Genes Dev (2007) 3.96
Requirement of DDX3 DEAD box RNA helicase for HIV-1 Rev-RRE export function. Cell (2004) 3.73
Folding, interaction with GRP78-BiP, assembly, and transport of the human immunodeficiency virus type 1 envelope protein. J Virol (1991) 3.62
Proteomic and biochemical analysis of purified human immunodeficiency virus type 1 produced from infected monocyte-derived macrophages. J Virol (2006) 3.59
Human immunodeficiency virus type 1, human protein interaction database at NCBI. Nucleic Acids Res (2008) 3.54
Human immunodeficiency virus cDNA metabolism: notable stability of two-long terminal repeat circles. J Virol (2002) 3.46
A probability-based approach for the analysis of large-scale RNAi screens. Nat Methods (2007) 3.34
Antiviral activity of the proteasome on incoming human immunodeficiency virus type 1. J Virol (1998) 3.21
The molecular basis of eukaryotic transcription. Proc Natl Acad Sci U S A (2007) 3.09
Central role of reverting mutations in HLA associations with human immunodeficiency virus set point. J Virol (2008) 2.72
Role of PSIP1/LEDGF/p75 in lentiviral infectivity and integration targeting. PLoS One (2007) 2.48
Nucleoporins nup98 and nup214 participate in nuclear export of human immunodeficiency virus type 1 Rev. J Virol (1999) 2.37
Transportin-SR2 imports HIV into the nucleus. Curr Biol (2008) 2.35
Human cell proteins and human immunodeficiency virus DNA integration. Front Biosci (2004) 2.32
LEDGF/p75 interacts with divergent lentiviral integrases and modulates their enzymatic activity in vitro. Nucleic Acids Res (2006) 2.22
Isolation of cDNAs encoding novel transcription coactivators p52 and p75 reveals an alternate regulatory mechanism of transcriptional activation. EMBO J (1998) 2.04
Bicyclams, a class of potent anti-HIV agents, are targeted at the HIV coreceptor fusin/CXCR-4. Antiviral Res (1997) 1.90
Knockdown screens to knockout HIV-1. Cell (2008) 1.73
Overlapping probabilities of top ranking gene lists, hypergeometric distribution, and stringency of gene selection criterion. Conf Proc IEEE Eng Med Biol Soc (2006) 1.67
Association of the Mediator complex with enhancers of active genes. Proc Natl Acad Sci U S A (2003) 1.55
Roles of host cell factors in circularization of retroviral dna. Virology (2003) 1.51
Akt inhibitors as an HIV-1 infected macrophage-specific anti-viral therapy. Retrovirology (2008) 1.44
A role for RNA helicase A in post-transcriptional regulation of HIV type 1. Proc Natl Acad Sci U S A (1999) 1.41
Association of RNA helicase a with human immunodeficiency virus type 1 particles. J Biol Chem (2006) 1.37
Modulating target site selection during human immunodeficiency virus DNA integration in vitro with an engineered tethering factor. Hum Gene Ther (2006) 1.27
Host proteins interacting with the Moloney murine leukemia virus integrase: multiple transcriptional regulators and chromatin binding factors. Retrovirology (2008) 1.20
DBR1 siRNA inhibition of HIV-1 replication. Retrovirology (2005) 1.08
HIV-1 infection: going nuclear with TNPO3/Transportin-SR2 and integrase. Curr Biol (2008) 1.06
Positive and negative modulation of human immunodeficiency virus type 1 Rev function by cis and trans regulators of viral RNA splicing. J Virol (2002) 0.97
The functionally conserved nucleoporins Nup124p from fission yeast and the human Nup153 mediate nuclear import and activity of the Tf1 retrotransposon and HIV-1 Vpr. Mol Biol Cell (2005) 0.96
The promise of genomics to identify novel therapeutic targets. Expert Opin Ther Targets (2004) 0.96
Baseline resistance of primary human immunodeficiency virus type 1 strains to the CXCR4 inhibitor AMD3100. J Virol (2008) 0.95
High-content screening of functional genomic libraries. Methods Enzymol (2006) 0.92
Apolipoprotein A-I increases association of cytosolic cholesterol and caveolin-1 with microtubule cytoskeletons in rat astrocytes. J Neurochem (2006) 0.82
Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res (2003) 103.76
Integration of biological networks and gene expression data using Cytoscape. Nat Protoc (2007) 27.10
Cytoscape 2.8: new features for data integration and network visualization. Bioinformatics (2010) 26.76
Global landscape of protein complexes in the yeast Saccharomyces cerevisiae. Nature (2006) 24.29
De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling. Nature (2004) 12.41
Network-based classification of breast cancer metastasis. Mol Syst Biol (2007) 12.18
A Bayesian networks approach for predicting protein-protein interactions from genomic data. Science (2003) 12.07
Exploration of the function and organization of the yeast early secretory pathway through an epistatic miniarray profile. Cell (2005) 10.41
Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif. Cell (2003) 9.48
Functional dissection of protein complexes involved in yeast chromosome biology using a genetic interaction map. Nature (2007) 9.25
Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication. Cell (2008) 8.41
Computational methods for the comparative quantification of proteins in label-free LCn-MS experiments. Brief Bioinform (2007) 8.26
Toward a comprehensive atlas of the physical interactome of Saccharomyces cerevisiae. Mol Cell Proteomics (2007) 7.93
Conserved patterns of protein interaction in multiple species. Proc Natl Acad Sci U S A (2005) 7.48
Raltegravir with optimized background therapy for resistant HIV-1 infection. N Engl J Med (2008) 7.33
Cotranscriptional set2 methylation of histone H3 lysine 36 recruits a repressive Rpd3 complex. Cell (2005) 7.21
Transcriptional regulation of protein complexes within and across species. Proc Natl Acad Sci U S A (2007) 7.07
Methylation of histone H3 by Set2 in Saccharomyces cerevisiae is linked to transcriptional elongation by RNA polymerase II. Mol Cell Biol (2003) 6.79
A travel guide to Cytoscape plugins. Nat Methods (2012) 6.53
Single-strand specificity of APOBEC3G accounts for minus-strand deamination of the HIV genome. Nat Struct Mol Biol (2004) 6.26
Genome-scale RNAi screen for host factors required for HIV replication. Cell Host Microbe (2008) 6.24
An atlas of combinatorial transcriptional regulation in mouse and man. Cell (2010) 6.24
Monosynaptic restriction of transsynaptic tracing from single, genetically targeted neurons. Neuron (2007) 6.22
Cyclophilin A modulates the sensitivity of HIV-1 to host restriction factors. Nat Med (2003) 5.97
Minimizing the risk of reporting false positives in large-scale RNAi screens. Nat Methods (2006) 5.96
Human capillary morphogenesis protein 2 functions as an anthrax toxin receptor. Proc Natl Acad Sci U S A (2003) 5.95
Anthrax toxin. Annu Rev Cell Dev Biol (2003) 5.92
Subgroup and resistance analyses of raltegravir for resistant HIV-1 infection. N Engl J Med (2008) 5.58
Damage recovery pathways in Saccharomyces cerevisiae revealed by genomic phenotyping and interactome mapping. Mol Cancer Res (2002) 5.42
Systematic interpretation of genetic interactions using protein networks. Nat Biotechnol (2005) 5.38
Human host factors required for influenza virus replication. Nature (2010) 5.28
Exploration of essential gene functions via titratable promoter alleles. Cell (2004) 5.21
RNA polymerase II elongation factors of Saccharomyces cerevisiae: a targeted proteomics approach. Mol Cell Biol (2002) 5.04
Modeling cellular machinery through biological network comparison. Nat Biotechnol (2006) 5.01
Navigating the chaperone network: an integrative map of physical and genetic interactions mediated by the hsp90 chaperone. Cell (2005) 4.95
In vivo genome editing restores haemostasis in a mouse model of haemophilia. Nature (2011) 4.81
The Parkinson's disease protein DJ-1 is neuroprotective due to cysteine-sulfinic acid-driven mitochondrial localization. Proc Natl Acad Sci U S A (2004) 4.76
TRIM28 mediates primer binding site-targeted silencing of murine leukemia virus in embryonic cells. Cell (2007) 4.70
Conserved pathways within bacteria and yeast as revealed by global protein network alignment. Proc Natl Acad Sci U S A (2003) 4.68
The yeast Rat1 exonuclease promotes transcription termination by RNA polymerase II. Nature (2004) 4.65
Bre1, an E3 ubiquitin ligase required for recruitment and substrate selection of Rad6 at a promoter. Mol Cell (2003) 4.49
A strategy for extracting and analyzing large-scale quantitative epistatic interaction data. Genome Biol (2006) 4.49
Conservation and rewiring of functional modules revealed by an epistasis map in fission yeast. Science (2008) 4.36
A phosphatase complex that dephosphorylates gammaH2AX regulates DNA damage checkpoint recovery. Nature (2005) 4.33
A global network of transcription factors, involving E2A, EBF1 and Foxo1, that orchestrates B cell fate. Nat Immunol (2010) 4.32
SAMHD1 restricts HIV-1 infection in resting CD4(+) T cells. Nat Med (2012) 4.27
Human Proteinpedia enables sharing of human protein data. Nat Biotechnol (2008) 4.21
INO80 and gamma-H2AX interaction links ATP-dependent chromatin remodeling to DNA damage repair. Cell (2004) 4.20
Restriction of multiple divergent retroviruses by Lv1 and Ref1. EMBO J (2003) 4.19
High-definition macromolecular composition of yeast RNA-processing complexes. Mol Cell (2004) 4.18
Rewiring of genetic networks in response to DNA damage. Science (2010) 4.03
enoLOGOS: a versatile web tool for energy normalized sequence logos. Nucleic Acids Res (2005) 4.03
Complementary profiling of gene expression at the transcriptome and proteome levels in Saccharomyces cerevisiae. Mol Cell Proteomics (2002) 3.89
A comprehensive strategy enabling high-resolution functional analysis of the yeast genome. Nat Methods (2008) 3.79
Differential network biology. Mol Syst Biol (2012) 3.74
Inhibition of retroviral RNA production by ZAP, a CCCH-type zinc finger protein. Science (2002) 3.73
Global landscape of HIV-human protein complexes. Nature (2011) 3.70
Functional genomic screen for modulators of ciliogenesis and cilium length. Nature (2010) 3.63
Hoxa9 and Meis1 are key targets for MLL-ENL-mediated cellular immortalization. Mol Cell Biol (2004) 3.62
Genome-wide and functional annotation of human E3 ubiquitin ligases identifies MULAN, a mitochondrial E3 that regulates the organelle's dynamics and signaling. PLoS One (2008) 3.59
APOBEC3B and APOBEC3C are potent inhibitors of simian immunodeficiency virus replication. J Biol Chem (2004) 3.56
A systems approach to mapping DNA damage response pathways. Science (2006) 3.55
Phenotypic landscape of a bacterial cell. Cell (2010) 3.50
Transitions in RNA polymerase II elongation complexes at the 3' ends of genes. EMBO J (2004) 3.50
Inferring pathway activity toward precise disease classification. PLoS Comput Biol (2008) 3.48
Complementary function of the two catalytic domains of APOBEC3G. Virology (2005) 3.45
Detailed identification of plasma proteins adsorbed on copolymer nanoparticles. Angew Chem Int Ed Engl (2007) 3.41
Diketo acid inhibitor mechanism and HIV-1 integrase: implications for metal binding in the active site of phosphotransferase enzymes. Proc Natl Acad Sci U S A (2002) 3.40
Insertion of green fluorescent protein into nonstructural protein 5A allows direct visualization of functional hepatitis C virus replication complexes. J Virol (2004) 3.39
A probability-based approach for the analysis of large-scale RNAi screens. Nat Methods (2007) 3.34
Learning a prior on regulatory potential from eQTL data. PLoS Genet (2009) 3.31
High-throughput genetic interaction mapping in the fission yeast Schizosaccharomyces pombe. Nat Methods (2007) 3.24
Histone H2B ubiquitylation is associated with elongating RNA polymerase II. Mol Cell Biol (2005) 3.20
PathBLAST: a tool for alignment of protein interaction networks. Nucleic Acids Res (2004) 3.20
Expression of the zinc-finger antiviral protein inhibits alphavirus replication. J Virol (2003) 3.19
High-throughput, quantitative analyses of genetic interactions in E. coli. Nat Methods (2008) 3.17
Functional organization of the S. cerevisiae phosphorylation network. Cell (2009) 3.15
Network-based stratification of tumor mutations. Nat Methods (2013) 3.12
A panoramic view of yeast noncoding RNA processing. Cell (2003) 3.11
Functional targeting of DNA damage to a nuclear pore-associated SUMO-dependent ubiquitin ligase. Science (2008) 3.09
Discovery of raltegravir, a potent, selective orally bioavailable HIV-integrase inhibitor for the treatment of HIV-AIDS infection. J Med Chem (2008) 3.09
A genetic interaction map of RNA-processing factors reveals links between Sem1/Dss1-containing complexes and mRNA export and splicing. Mol Cell (2008) 2.96